Literature DB >> 9358431

In vitro effect of garlic powder extract on lipid content in normal and atherosclerotic human aortic cells.

A N Orekhov1, V V Tertov.   

Abstract

In the present study, the mechanism of the in vitro effect of garlic powder extract (GPE) on lipid content of cultured human aortic cells was investigated. The addition of GPE abolished atherogenic blood serum-induced accumulation of free cholesterol, triglycerides, and cholesteryl esters in smooth muscle cells derived from uninvolved (normal) intima. In cells isolated from atherosclerotic plaque, GPE lowered these lipids. GPE inhibited lipid synthesis both in normal and atherosclerotic cells. It inhibited acyl-CoA:cholesterol acyltransferase activity that participates in the cholesteryl ester formation and stimulated cholesteryl ester hydrolase that degrades cholesteryl esters. This may explain the lipid reduction caused by GPE in atherosclerotic cells. GPE inhibited the uptake of modified low density lipoprotein and degradation of lipoprotein-derived cholesteryl esters, thus considerably reducing the intracellular accumulation of cholesteryl esters. This suggests the mechanism responsible for the prevention of lipid accumulation in aortic cells caused by atherogenic blood serum.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358431     DOI: 10.1007/s11745-997-0136-7

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  23 in total

1.  Effect of garlic on thrombocyte aggregation, microcirculation, and other risk factors.

Authors:  H Kiesewetter; F Jung; G Pindur; E M Jung; C Mrowietz; E Wenzel
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1991-04

2.  Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination.

Authors:  A N Orekhov; V V Tertov; S N Pokrovsky; O N Martsenyuk; A A Lyakishev; V N Smirnov
Journal:  Circ Res       Date:  1988-03       Impact factor: 17.367

3.  Lipid extraction of tissues with a low-toxicity solvent.

Authors:  A Hara; N S Radin
Journal:  Anal Biochem       Date:  1978-10-01       Impact factor: 3.365

4.  Inhibition of cholesterol synthesis in vitro by extracts and isolated compounds prepared from garlic and wild garlic.

Authors:  A Sendl; M Schliack; R Löser; F Stanislaus; H Wagner
Journal:  Atherosclerosis       Date:  1992-05       Impact factor: 5.162

5.  Lipid composition of human serum lipoproteins.

Authors:  V P Skipski; M Barclay; R K Barclay; V A Fetzer; J J Good; F M Archibald
Journal:  Biochem J       Date:  1967-08       Impact factor: 3.857

6.  Triggerlike stimulation of cholesterol accumulation and DNA and extracellular matrix synthesis induced by atherogenic serum or low density lipoprotein in cultured cells.

Authors:  A N Orekhov; V V Tertov; S A Kudryashov; V N Smirnov
Journal:  Circ Res       Date:  1990-02       Impact factor: 17.367

7.  Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency.

Authors:  A N Orekhov; V V Tertov; D N Mukhin
Journal:  Atherosclerosis       Date:  1991-02       Impact factor: 5.162

8.  Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.

Authors:  V V Tertov; I A Sobenin; Z A Gabbasov; E G Popov; O Jaakkola; T Solakivi; T Nikkari; V N Smirnov; A N Orekhov
Journal:  Lab Invest       Date:  1992-11       Impact factor: 5.662

9.  Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography.

Authors:  V V Tertov; I A Sobenin; A G Tonevitsky; A N Orekhov; V N Smirnov
Journal:  Biochem Biophys Res Commun       Date:  1990-03-30       Impact factor: 3.575

10.  Lipids in cells of atherosclerotic and uninvolved human aorta. I. Lipid composition of aortic tissue and enzyme-isolated and cultured cells.

Authors:  A N Orekhov; V V Tertov; I D Novikov; A V Krushinsky; E R Andreeva; V Z Lankin; V N Smirnov
Journal:  Exp Mol Pathol       Date:  1985-02       Impact factor: 3.362

View more
  5 in total

1.  Garlic ameliorates hyperlipidemia in chronic aminonucleoside nephrosis.

Authors:  J Pedraza-Chaverrí; O N Medina-Campos; M A Granados-Silvestre; P D Maldonado; I M Olivares-Corichi; R Hernández-Pando
Journal:  Mol Cell Biochem       Date:  2000-08       Impact factor: 3.396

2.  Anti-atherosclerotic therapy based on botanicals.

Authors:  Alexander N Orekhov; Igor A Sobenin; Nikolay V Korneev; Tatyana V Kirichenko; Veronika A Myasoedova; Alexandra A Melnichenko; Mercedes Balcells; Elazer R Edelman; Yuri V Bobryshev
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2013-04

3.  Effects of garlic on brachial endothelial function and capacity of plasma to mediate cholesterol efflux in patients with coronary artery disease.

Authors:  Marjan Mahdavi-Roshan; Parvin Mirmiran; Mohammad Arjmand; Javad Nasrollahzadeh
Journal:  Anatol J Cardiol       Date:  2017-05-24       Impact factor: 1.596

4.  Does Garlic Supplementation Control Blood Pressure in Patients with Severe Coronary Artery Disease? A Clinical Trial Study.

Authors:  Marjan Mahdavi-Roshan; Javad Nasrollahzadeh; Ali Mohammad Zadeh; Ali Zahedmehr
Journal:  Iran Red Crescent Med J       Date:  2016-08-24       Impact factor: 0.611

Review 5.  Roles and mechanisms of garlic and its extracts on atherosclerosis: A review.

Authors:  Min Li; Wingyan Yun; Guibin Wang; Anqi Li; Jing Gao; Qingyong He
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.